Table 2.
Laboratory findings.
| Reference values | Admission day (n = 33) | Follow up (n = 33) | |
| Hematology | |||
| - White blood cells, × 109/L | 4.0–10.0 | 6.9 {5.1–7.9} | 6.5 {5.6–7.4} |
| - Hemoglobin, g/dl | m: 14.0-18.0 | 13.9 {11.8–14.9} | 13.6 {11.7–14.5} |
| w: 12.0-16.0 | |||
| - Platelets, × 109/L | 150–400 | 205 {164–241} | 262 {202–303} |
| - Lymphocytes, % | 22.0–53.0 | 11.9 {9.4–21.0} | 26.7 {20.6–33.8} |
| - Eosinophils, % |
1.0–6.0 |
0.1 {0–0.2} |
2.1 {1.4–3.0} |
|
Coagulation | |||
| - INR | 1.2 {1.1–1,2} | 1 {0.9–1.2} | |
| - aPTT, sec. | 25.1–36.5 | 27.2 {25.2–29.3} | 29.0 {27.8–31.4} |
| - Antithrombin III, % | 80–120 | – | 107 {96–114} |
| - Fibrinogen, mg/dl | 238–498 | – | 342 {293–391} |
| - D-dimer, ng/ml | < 500 | 855 {739–873} | 474 {323–675} |
| - Thrombin time, sec. |
10–17 |
21 {17.4–24.5} |
15 {14-16} |
|
Clinical Chemistry | |||
| - HbA1c, % | < 5.7 | 5.9 {5.5–6.8} | 5.3 {5.0–6.1} |
| - Sodium, mmol/l | 136–145 | 138 {136–141} | 141 {139–143} |
| - Potassium, mmol/l | 3.6–5.5 | 4.2 {3.8–4.7} | 4.5 {4.3–4.7} |
| - Phosphate, mmol/l | 0.81–1.45 | – | 0.97 {0.85–1.12} |
| - Cholesterol, mg/dl | < 200 | 145 {116–195} | 177 {135–231} |
| - HDL-cholesterol, mg/dl | > 45 | 35 {30-40} | 50 {45–55} |
| - LDL-cholesterol, mg/dl | < 130 | 86 {66–140} | 118 {77–161} |
| - Triglycerides, mg/dl | < 200 | 109 {93–189} | 140 {107–196} |
| - Lipoprotein (a), nmol/l | < 75 | – | 23 {9-32} |
| - Albumin, g/dl | 3.5–5.2 | 3.8 {3.5–4.2} | 4.3 {4.1–4.6} |
| - Bilirubin (total), mg/dl | < 1.2 | 0.6 {0.5–0.6} | 0.43 {0.29–0.67} |
| - AST, U/l | < 35 | 48 {32–60} | 24 {20-29} |
| - ALT, U/l | < 35 | 29 {22-40} | 24 {17-39} |
| - Gamma-GT, U/l | < 40 | 29 {22–84} | 30 {17–46} |
| - AP, U/l | 35–105 | 64 {50–82} | 74 {56–85} |
| - LDH, U/l | m: 135-225 | 324 {258–438} | 213 {196–227} |
| w: 135-214 | |||
| - CK, U/l | m: < 174 | 129 {82–337} | 84 {49–109} |
| w: < 140 | |||
| - CK-MB-Mass, U/l | < 26 U/l | – | 2 {1.5–3.0} |
| - hs-Troponin T, pg/ml | < 14.0 | 21 {9–140} | 8 {4-21} |
| - NT-proBNP, pg/ml | < 220 | 147 {27–710} | 183 {43–474} |
| - Urea, mg/dl | 16.6–48.5 | 32 {23-42} | 36 {28–47} |
| - Creatinine, mg/dl | 0.5–1.2 | 1 {0.8–1.1} | 0.88 {0.79–1.13} |
| - CRP, mg/l | < 5 | 57.1 {20.9–103.1} | 2.0 {1.1–7.9} |
| - Procalcitonin, ng/ml |
< 0.5 |
0.1 {0.1–0.2} |
0.05 {0.04–0.06} |
|
Iron metabolism | |||
| - Iron, μg/dl | 33–193 | – | 79.3 {60.5–99.1} |
| - Transferrin saturation, % | 16.0–45.0 | – | 20.4 {15.3–26.5} |
| - Ferritin, ng/ml |
15.0–150.0 |
1140.5 {955–1196.8} |
154.6 {81.8–362.8} |
|
Proteins | |||
| - Cystatin C, mg/l | 0.61–0.95 | – | 1.03 {0.96–1.42} |
| - Myoglobin, μg/l |
25–58 |
34 {34-34} |
27 {21–55} |
|
Thyroid parameters | |||
| - TSH, mU/l | 0.27–4.20 | 1.5 {1.1–1.8} | 1.6 {1.1–2.2} |
| - fT3, ng/l | 2.0–4.4 | 1.8 {1.7–2.4} | 3.2 {2.7–3.4} |
| - fT4, ng/dl |
0.9–1.7 |
1.2 {1.1–1.4} |
1.1 {1.1–1.2} |
|
Cytokines | |||
| - sIL-2-receptor, U/ml | 158–623 | – | 470 {401–602} |
| - IL-6, pg/ml | < 7.0 | 64.2 {38.5–106.9} | 2.4 {1.5–3.9} |
| - TNF alpha, pg/ml | < 8.1 | – | 8.1 {5.8–9.8} |
Values are median {interquartile range}.
ABBREVIATIONS: ALP = alkaline phosphatase; ALT = alanine transaminase; aPTT = activated partial thromboplastin time; AST = aspartate transaminase; CK = creatine kinase; CKmb = creatine kinase myocardial band; CRP = C-reactive protein; FT3 = unbound triiodothyronine; FT4 = unbound thyroxine; Gamma-GT = gamma-glutamyltransferase; HbA1c = glycated hemoglobin; HDL = high-density lipoprotein; hs-Troponin-T = high sensitive Troponin-T; IL-6 = interleukin-6; INR = international normalized ratio; LDH = lactate dehydrogenase; LDL = low-density lipoprotein; NT-proBNP = N-terminal pro B-type natriuretic peptide; sIL 2 = soluble interleukin‐2 receptor; TNF = tumor necrosis factor; TSH = thyroid-stimulating hormone.